Why to avoid dual primary endpoints in cardiovascular trials

Back

ESC Professional Premium Access

Why to avoid dual primary endpoints in cardiovascular trials

Session: Epidemiological trends in cardiovascular medicine: a data-driven approach

Topic: Biostatistics

Speaker: Ms N. Thomas (Hannover, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Nele Henrike Thomas

Institute for Biostatistics, Hannover (Germany)

0 follower

4 more presentations in this session

What is the evidence behind new I-A and III-A recommendations in European Society of Cardiology guidelines?

Speaker: Doctor R. Bansal (Oxford, GB)

Major cardiovascular events after admission to intensive care units: A Danish nationwide cohort study

Speaker: Doctor K. Feldballe Bernholm (Copenhagen, DK)

Ketone body ratio as a predictor of heart failure incidence: findings from a 15-year longitudinal cohort study

Speaker: Doctor K. Saadeh (Birmingham, GB)

Metabolic signature of prevalent cardiovascular diseases

Speaker: Mr M. Dziedzic (Cracow, PL)

Access the full session

Epidemiological trends in cardiovascular medicine: a data-driven approach

Speakers: Ms N. Thomas, Doctor R. Bansal, Doctor K. Feldballe Bernholm, Doctor K. Saadeh, Mr M. Dziedzic

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources